Medical Devices · Henderson, Nevada, United States
$0.38
-0.10% (-$0.00)2026-08-25
Revenue$398.7K
Net Income-$7.3M
EPS$-1.80
Market Cap$4.6M
Price Performance
Historical data including institutional events
Company Profile
C
Cameron Reynolds
CEO & Executive Director
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia.
The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patientâs cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
VolitionRx Limited is based in Henderson, Nevada.
